N (%) | 7-day mortality (%) | |
---|---|---|
All patients | 745 | 149 (20.0) |
Sex (male) | 302 (40.5) | 83 (18.7) |
Age, years* | 69 (54;79) | |
Age groups | ||
< 18 years | 16 (2.1) | 0 (0) |
18–39 years | 85 (11.4) | 5 (5.9) |
40–59 years | 149 (20.0) | 12 (8.1) |
60–79 years | 309 (41.5) | 71 (23.0) |
≥ 80 years | 186 (25.0) | 61 (32.8) |
Charlson’s comorbidity index | ||
0–2 | 595 (79.9) | 118 (19.8) |
3–4 | 100 (13.4) | 18 (18.0) |
≥ 5 | 50 (6.7) | 13 (26.0) |
Final diagnosis group** | ||
Unclassified symptoms [18] | 165 (22.1) | 26 (15.8) |
Respiratory system [10] | 125 (16.8) | 18 (14.4) |
Injuries [19] | 91 (12.2) | 6 (6.6) |
Circulatory system [9] | 85 (11.4) | 50 (58.8) |
Unclassified causes [21] | 71 (9.5) | 12 (16.9) |
Infection [1] | 41 (5.5) | 10 (24.4) |
Endocrine/metabolic [4] | 18 (2.4) | < 4 |
Digestive system [11] | 18 (2.4) | < 4 |
Nervous system[6] | 15 (2.0) | < 4 |
Other | 22 (3.0) | 4 (18.2) |
No diagnosis*** | 94 (12.6) | 16 (17.0) |
Lactate group (mmol/L) | ||
< 2.0 | 295 (39.6) | 34 (11.5) |
2.0 – 3.9 | 180 (24.2) | 26 (14.4) |
≥ 4.0 | 270 (36.2) | 89 (33.0) |
pH group | ||
< 7.35 | 355 (47.7) | 112 (31.5) |
7.35 – 7.45 | 275 (36.9) | 24 (8.7) |
≥ 7.45 | 115 (15.4) | 13 (11.3) |
pCO2 group | ||
< 4.3 | 108 (14.5) | 27 (25.0) |
4.3 – 6.0 | 293 (39.3) | 34 (11.6) |
≥ 7.45 | 344 (46.2) | 88 (25.6) |